Medicare billing address
CMS Medicare provider billing file
1101 Chestnut StPhila, PA 19107
CMS public data · NPI 1619936515
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Michael C Dimarino, M.D.
Specialty
Credential
M.D.
NPI
1619936515
Primary source state
PA
Data retrieval date
July 28, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Michael C Dimarino, M.D. from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
1101 Chestnut StCMS Doctors & Clinicians file
132 S 10Th StCMS Doctors & Clinicians file
26 E Red Bank AveCMS Doctors & Clinicians file
443 Laurel Oak RdIn the 2024 CMS provider billing file, this NPI had 688 Medicare beneficiaries and 4,523 total services. The average beneficiary age was 73, and the average HCC risk score was 1.5.
Total Medicare allowed amount
$236,672.91
Total Medicare payment amount
$184,567.17
Medicare beneficiaries
688
Total services
4,523
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hyperlipidemia
75%
CMS beneficiary-panel share
Hypertension
75%
CMS beneficiary-panel share
Diabetes
35%
CMS beneficiary-panel share
Ischemic heart disease
35%
CMS beneficiary-panel share
Anxiety
31%
CMS beneficiary-panel share
Chronic kidney disease
27%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 272 | $133.60 |
| Biopsy of large bowel using a flexible endoscope | 152 | $119.82 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 139 | $81.17 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 100 | $252.18 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 98 | $134.31 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 83 | $78.52 |
| New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more | 74 | $175.47 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 55 | $98.12 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 36 | $178.32 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 22 | $121.91 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1619936515. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Omeprazole | Omeprazole | 310 | 849.6 | $5,098.43 |
| 2 | Pantoprazole Sodium | Pantoprazole Sodium | 149 | 427.8 | $2,397.69 |
| 3 | Dicyclomine Hcl | Dicyclomine Hcl | 106 | 184.2 | $2,688.60 |
| 4 | Linzess | Linaclotide | 90 | 180 | $92,114.82 |
| 5 | Famotidine | Famotidine | 86 | 236 | $2,458.18 |
| 6 | Ondansetron Odt | Ondansetron | 54 | 60 | $1,106.96 |
| 7 | Dexlansoprazole Dr | Dexlansoprazole | 53 | 141 | $26,189.84 |
| 8 | Esomeprazole Magnesium | Esomeprazole Magnesium | 43 | 110.5 | $1,634.89 |
| 9 | Xifaxan | Rifaximin | 42 | 42 | $115,630.76 |
| 10 | Sucralfate | Sucralfate | 38 | 66.6 | $4,794.21 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Medical school
Hahnemann University College Of Medicine
Graduation year
1994
Group/practice field
Jefferson University Physicians
Telehealth reported
Yes
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.